Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel antitumor compounds

A compound, selected technology, applied in the field of disease and tumor-related diseases, can solve the problem of no curative effect, etc.

Active Publication Date: 2016-03-02
NANJING HUAWE MEDICINE TECH DEV
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Tumor chemotherapy has made some progress, significantly prolonging the survival time of patients, but still has not achieved satisfactory curative effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel antitumor compounds
  • Novel antitumor compounds
  • Novel antitumor compounds

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0067]

[0068] Take compound 22 methyl vanillate (73g, 0.4mol) and 1-bromo-3-chloropropane (94g, 0.6mol) mixed into a 1L three-necked round bottom flask, measure 500ml of N,N-methylformamide ( DMF) was stirred and dissolved, and 80g potassium carbonate was added with heating and stirring at 40°C. The reaction progress was detected by TLC (petroleum ether: ethyl acetate=2:1, UV color development). The reaction was basically completed in 4 to 5 hours to obtain the reaction solution of compound 23. It can be used directly in the next reaction.

[0069] Take 30g potassium carbonate, 20g potassium iodide and 70g morpholine directly into the reaction solution of compound 23, heat and stir overnight at 75°C, TLC detection (petroleum ether: ethyl acetate=2:1, UV color), the raw materials are basically reacted and filtered To remove insoluble matter, the filter cake was washed with dichloromethane, the filtrate was concentrated to remove most of DMF, diluted with about 800ml of water, ex...

Embodiment 7

[0079]

[0080] Weigh 0.2g of compound 30 and 0.23g of compound 35 and mix them with about 50mL of absolute ethanol. Add 0.07g of triethylamine, 0.02g of KI at 80°C and heat and stir, react for 72h, monitor by TCL (dichloromethane: methanol: ammonia = 10: 1:0.1) To the end of the reaction, 0.09 g of compound 36 was purified by column chromatography.

[0081] MSm / z(ESI): 638[M+H] +1 ; H-NMR(500MHz, deuterated DMSO: δ:8.45(d.2H), 8.26(m.1H), 7.92(m.1H), 7.38(m.2H) 4.62(s.2H), 4.21(t .2H), 4.01(s.3H), 3.61~3.70(m.4H), 3.58(m.2H), 2.83(t.2H), 2.46~2.48(t.4H), 1.96(m.2H).

Embodiment 8

[0083]

[0084] Weigh 2.7g of compound 30 and 4g of anhydrous piperazine and mix them with about 50mL of absolute ethanol. Add 1g of triethylamine, 0.2g of potassium iodide and heat and stir at 80°C, react for 48h, and monitor by TCL (dichloromethane: methanol: ammonia = 10:1:0.1) to the end of the reaction, then concentrate to remove the ethanol, add 100mL water, extract with 50mL*3 dichloromethane, combine the organic phases, wash the organic phase with 100mL*2 saturated ammonium chloride solution and then use 100mL*2 It was washed twice with water, dried over anhydrous sodium sulfate, and concentrated to obtain 1.5 g of compound 37.

[0085] MSm / z(ESI): 464;

[0086] 1 H-NMR (500MHz, deuterated DMSO: δ: 8.45(d.2H), 8.26(m.1H), 7.92(m.1H), 7.38(m.2H), 4.62(s.2H), 4.21(t .2H), 4.01(s.3H), 3.61(t.2H), 3.29(t.2H), 2.83(t.2H), 2.46~2.48(t.4H).

[0087] Compound 38, compound 39, compound 40, compound 42, compound 43, and compound 44 have structural units similar to compound 37 or comp...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a compound represented by formula (I), its pharmaceutically acceptable salt or its solvate, and the above compound for the prevention and / or treatment of tumors and other tumor-related diseases. Wherein the definition of each substituent in the formula (I) is the same as the definition in the description.

Description

Technical field [0001] The field belongs to the technical field of medicinal chemistry, and specifically relates to a new anti-tumor compound and its use for treating or preventing tumors and other diseases and tumor-related diseases. Background technique [0002] At present, tumor is still one of the most common and serious diseases that directly endanger human life in the world today. Cancer chemotherapy has made some progress, significantly prolonging the survival time of patients, but still has not achieved satisfactory results. In recent years, the in-depth study of oncology and the molecular level of tumor focus and the discovery of many new therapeutic targets have provided the possibility for the development of new anti-tumor drugs. With the continuous deepening of research on tumor cell signal transduction pathways, the design and research of new anti-tumor drugs has attracted more and more attention. [0003] Gefitinib is an anti-tumor drug developed by the British comp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D409/12C07D409/14C07D401/06C07D401/14C07D405/14A61K31/5377A61K31/502A61P35/00
CPCC07D237/34C07D401/06C07D401/14C07D405/14C07D409/12C07D409/14A61P35/00C07D237/30
Inventor 张孝清宋志春包金远蒋玉伟冯慧慧苏梅
Owner NANJING HUAWE MEDICINE TECH DEV